Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $2.1B bought by 554 insiders at 344 companies
- $9.7B sold by 665 insiders outside a trading plan
- $4.6B sold by 965 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past month · by insider, all their filings added up
-
LENLennar CorporationBerkshire Hathaway Inc.10% owner · +1 joint filer$595M
-
RSGRepublic Services, Inc.Cascade Investment, L.l.c.10% owner · +1 joint filer$454M
-
GPIGroup 1 Automotive, Inc.Conifer Management, L.L.C.10% owner$179M
-
CRBGCorebridge Financial Inc.Life Insurance Co Nippon10% owner$158M
-
KODKodiak Sciences IncBaker Bros. Advisors LPDirector · +5 joint filers$157M
-
UUUUniversal Safety Products, Inc.Milton C Ault IIIDirector$92.5M
-
GMEGameStop CorporationRyan CohenCEO$74.4M
-
FTKFlotek Industries, Inc.Matthew WilksDirector$34.3M
-
PAMTPamt Corp.Matthew T MorounDirector$31.2M
-
GRABGrab Holdings LimitedAnthony Ping Yeow TanCEO$29.9M
Biggest sales
Past month · by insider, all their filings added up · planned sales marked
-
FANGDiamondback Energy, Inc.SGF FANG Holdings, LP10% owner · +1 joint filer$3.7B
-
MDLNMedline Inc.GIC Private Ltd10% owner · +2 joint filers$722M
-
NVDANvidia Corporation ComMark A StevensDirector$536M
-
INGMIngram Micro Holding CorporationPlatinum Equity, LLC10% owner · +9 joint filers$410M
-
IHTInnSuites Hospitality TrustMarc E BergEVP & Secretary/Treasurer$361M
-
DELLDell Technologies Inc.Silver Lake Partners IV, L.P.Director · +4 joint filers$356M
-
DELLDell Technologies Inc.Sl Spv-2, L.P.Director · +4 joint filers$289M
-
AVGOBroadcom Inc.Henry SamueliDirector$250M
-
CHYMChime Financial, Inc.DST Global Advisors Ltd10% owner · +9 joint filers$237M
-
UMCUnited Microelectronics CorporationChitung LiuCFO$229M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days · most buyers first
-
Che-Chia Wei CEO, Yung-Pei Chin COO, Kevin Xiaoqiang Zhang COO, Shien-Yang Wu SVP, +17 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
Milena Maria Pappa Director, Raffaele Zagari Director, Symeon Spyrou CFO, Nikolaos Reskos COO, +3 more
-
Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, Trangsrud Teresa J Rasmussen Director, +3 more
-
Christopher J Abate CEO, Dashiell I Robinson President, Greg H Kubicek Director, Brooke Carillo CFO, +2 more
-
Matthew G De Soto Director, Albert J. Evans Director, Rory G Ritrievi CEO, Joel L. Frank Director, +2 more
-
Ryan Cohen CEO, Lawrence Cheng Director, Alain Attal Director, Nat Turner Director, +1 more
-
Tricor PMT25 Holdings Inc. 10% owner, H Sanford Riley Chair, Nicholas Peters Director, Marc Sheinbaum Director, +1 more
-
Avenue RP Opportunities Fund, L.P. 10% owner, Par Chadha Director, Avenue Global Opportunities Master Fund LP 10% owner, Andrej Jonovic CEO, +1 more
-
Lawrence B Seidman Director, Eric J Dale Director, Carl M Porto Director, Jeffrey R Dunne Director, +1 more
All insider trades
Newest filings first · one row per filing · every open-market buy and sale
-
Phyllis B Nordstrom CFODDD3D Systems CorporationSale$107K 30,000 shares at $3.58 4% of stakeTraded Sep 17 Filed Sep 18
-
Lingke Wang PresidentLIFEEthos Technologies Inc.Planned sale$4.6M 118,333 shares at $38.96 7.1% of stakeTraded Sep 17 Filed Sep 18
-
Peter George Colis CEOLIFEEthos Technologies Inc.Planned sale$2.7M 70,000 shares at $38.51 4.4% of stakeTraded Sep 16–18 Filed Sep 18
-
Kathleen Goin COOPVLAPalvella Therapeutics, Inc.Planned sale$655K 4,302 shares at $152.24 100% of stakeTraded Sep 16 Filed Sep 18
-
Tajinder S Vohra Please See RemarksRVTYRevvity, Inc.Planned sale$1M 7,330 shares at $140.88 53% of stakeTraded Sep 16 Filed Sep 18
-
Jeffrey A Graves CEODDD3D Systems CorporationSale$152K 42,686 shares at $3.55 3.3% of stakeTraded Sep 17 Filed Sep 18
-
Daniel Schumacher CFOPRLBProto Labs, Inc.Planned sale$426K 5,000 shares at $85.21 11% of stakeTraded Sep 16–17 Filed Sep 18
-
Robert L Bugbee PresidentSTNGScorpio Tankers Inc.Sale$22.2M 256,799 shares at $86.28 29% of stakeTraded Sep 16–17 Filed Sep 18
-
Sherry Diaz ControllerGLREGreenlight Reinsurance, Ltd.Sale$204K 13,500 shares at $15.08 13% of stakeTraded Sep 17 Filed Sep 18
-
Cameron Keyser Mackey COOSTNGScorpio Tankers Inc.Sale$11.1M 125,000 shares at $89.03 15% of stakeTraded Sep 17 Filed Sep 18
-
Christopher John Avella CFOSTNGScorpio Tankers Inc.Sale$4.9M 56,500 shares at $86.57 24% of stakeTraded Sep 16 Filed Sep 18
-
Jeffrey Scott Sanfrey COOBLBDBlue Bird CorporationSale$250K 4,000 shares at $62.40 10% of stakeTraded Sep 16 Filed Sep 18
-
Yasuhiro Ito Chief People Officer (CPO)SONYSony Group CorporationSale$219K 9,000 shares at $24.29 58% of stakeTraded Sep 16 Filed Sep 18
-
Eynav Azaria See RemarksKLTRKaltura, Inc.Planned sale$19K 13,604 shares at $1.42 0.7% of stakeTraded Sep 16–17 Filed Sep 18
-
Auste Adelborg SecretarySTNGScorpio Tankers Inc.Sale$613K 6,834 shares at $89.64 100% of stakeTraded Sep 17 Filed Sep 18
-
David Meleh Aviv Chief Technology OfficerRDWRRadware Ltd.Sale$461K 15,000 shares at $30.71 10% of stakeTraded Sep 17 Filed Sep 18
-
Or Offer CEOSMWBSimilarweb Ltd.Planned sale$638K 76,119 shares at $8.38 1.8% of stakeTraded Sep 16–17 Filed Sep 18
-
William E. Rote Chief Research OfficerTVTXTravere Therapeutics, Inc.Planned sale$13.1M 209,048 shares at $62.83 68% of stakeTraded Sep 15–16 Filed Sep 17
-
Jonathan Sheena FounderNTRANatera, Inc.Planned sale$3.2M 9,150 shares at $351.49 4% of stakeTraded Sep 15–16 Filed Sep 17
-
Peter Heerma EVP, Chief Commercial OfficerTVTXTravere Therapeutics, Inc.Planned sale$17.9M 283,189 shares at $63.06 71% of stakeTraded Sep 15–17 Filed Sep 17
-
Jula Inrig EVP, Head of R&D & CMOTVTXTravere Therapeutics, Inc.Planned sale$2.8M 44,674 shares at $62.34 31% of stakeTraded Sep 15 Filed Sep 17
-
Elizabeth E Reed Chief Legal Officer and GCTVTXTravere Therapeutics, Inc.Planned sale$2.3M 37,500 shares at $62.34 26% of stakeTraded Sep 15 Filed Sep 17
-
Eric M Dube CEOTVTXTravere Therapeutics, Inc.Planned sale$25.4M 400,000 shares at $63.48 48% of stakeTraded Sep 15–17 Filed Sep 17
-
Christopher R. Cline CFOTVTXTravere Therapeutics, Inc.Planned sale$3.1M 50,508 shares at $62.34 37% of stakeTraded Sep 15 Filed Sep 17
-
Sandra Calvin SVP, Chief Accounting OfficerTVTXTravere Therapeutics, Inc.Planned sale$335K 5,375 shares at $62.33 11% of stakeTraded Sep 15 Filed Sep 17
-
Kiran Kumar Choudary CFORBRKRubrik, Inc.Planned sale$1M 10,000 shares at $104.81 1% of stakeTraded Sep 15–17 Filed Sep 17
-
Joan M Herman EVP, OperationsPAYSPaysign, Inc.Planned sale$717K 59,904 shares at $11.97 8.9% of stakeTraded Sep 15–16 Filed Sep 17
-
Jeffrey M Thompson CEORCATRed Cat Holdings, Inc.Planned sale$1.2M 150,000 shares at $7.74 1.3% of stakeTraded Sep 15 Filed Sep 17
-
Xingjuan Chao CEOCBLLCeriBell, Inc.Planned sale$522K 20,846 shares at $25.03 2.7% of stakeTraded Sep 15 Filed Sep 17
-
Scott Blumberg CFOCBLLCeriBell, Inc.Planned sale$21K 846 shares at $25.00 0.6% of stakeTraded Sep 15 Filed Sep 17
-
Michael D. Sicilia CEOORCLOracle CorporationPlanned sale$1.5M 10,882 shares at $139.94 6.8% of stakeTraded Sep 16 Filed Sep 17
-
Rukmini Sivaraman CFONTNXNutanix, Inc.Planned sale$2.7M 38,139 shares at $70.00 11% of stakeTraded Sep 17 Filed Sep 17
-
George Kurtz CEOCRWDCrowdStrike Holdings, Inc.Planned sale$4.8M 20,000 shares at $242.47 0.3% of stakeTraded Sep 15–16 Filed Sep 17
-
Philippe Le Bris Chief Accounting OfficerLGNLegence Corp.Planned sale$227K 4,196 shares at $54.06 41% of stakeTraded Sep 15 Filed Sep 17
-
Mark Locke CEOGENIGenius Sports LimitedSale$5.3M 800,000 shares at $6.57 4% of stakeTraded Sep 15–17 Filed Sep 17
-
Philipp Wolfgang Josef Kandal Chief Product OfficerGRABGrab Holdings LimitedPlanned sale$92K 30,000 shares at $3.08 0.8% of stakeTraded Sep 15 Filed Sep 17
-
Christopher Bohrson Chief Recurring OfficerCOHUCohu, Inc.Planned sale$51K 1,000 shares at $51.07 0.6% of stakeTraded Sep 15, 2025 Filed Sep 17
-
Peter Henry Oey CFOGRABGrab Holdings LimitedPlanned sale$145K 50,000 shares at $2.90 0.7% of stakeTraded Sep 15 Filed Sep 17
-
Marie Mendoza SVP & General CounselKTOSKratos Defense & Security Solutions, Inc.Planned sale$49K 1,000 shares at $48.50 1.6% of stakeTraded Sep 15 Filed Sep 17
-
Adam Geller Chief Product OfficerZSZscaler, Inc.Planned sale$880K 4,584 shares at $192.01 11% of stakeTraded Sep 17 Filed Sep 17
-
Phillip D Carrai President, STC DivisionKTOSKratos Defense & Security Solutions, Inc.Planned sale$311K 6,500 shares at $47.83 3.6% of stakeTraded Sep 15 Filed Sep 17
-
Michael N Intrator CEOCRWVCoreWeave, Inc.Planned sale$25.2M 307,692 shares at $81.91Traded Sep 15 Filed Sep 17
-
Mike Slessor CEOFORMFormFactor, Inc.Planned sale$1.8M 17,510 shares at $104.73 3.6% of stakeTraded Sep 16 Filed Sep 17
-
Benjamin Louis Kirchhoff Chief Accounting OfficerIOTSamsara Inc.Planned sale$92K 2,165 shares at $42.55 1.4% of stakeTraded Sep 15 Filed Sep 17
-
Thomas M Siebel CEOAIC3.ai, Inc.Planned sale$4.8M 444,248 shares at $10.77 38% of stakeTraded Sep 15–16 Filed Sep 17
-
Susan Bobulsky Chief Commercial Officer, MRDADPTAdaptive Biotechnologies CorporationPlanned sale$32K 1,195 shares at $27.00 0.3% of stakeTraded Sep 15 Filed Sep 17
-
Thomas Carlton Stewart See RemarksCGCCanopy Growth CorporationSale$24K 25,755 shares at $0.9300 4.2% of stakeTraded Sep 17 Filed Sep 17
-
Sean Searby EVP Chief Info. & Ops. OfficerAMALAmalgamated Financial Corp.Planned sale$158K 3,314 shares at $47.75 16% of stakeTraded Sep 15 Filed Sep 17
-
Jennifer Newstead SVP, GC and Government AffairsAAPLApple Inc ComPlanned sale$475K 1,438 shares at $330.19 4.2% of stakeTraded Sep 15 Filed Sep 17
-
Ashley F. Johnson CFOPLPlanet Labs PBCPlanned sale$944K 55,663 shares at $16.96 8.8% of stakeTraded Sep 17 Filed Sep 17
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,793 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.